Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Trading Update

31 Mar 2020 07:00

RNS Number : 1233I
De La Rue PLC
31 March 2020
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No.596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

31 March 2020

 

 

DE LA RUE PLC

 TRADING UPDATE

 

De La Rue plc (LSE: DLAR) ("De La Rue", the "Group" or the "Company") today announces a post period end trading update for the financial year ended 27 March 2020.

Current trading

The Board expects De La Rue adjusted operating profit for financial year (FY) 2019/20 to be between £20m and £25m, as previously guided.

The Group has operated within its banking covenants for FY 2019/20, including the net debt/EBITDA covenant of ≤3.0 times and expects net debt/EBITDA at the financial year end to be between 2.0 and 2.4 times, a reduction on the 2.72 times ratio at half year 2019/20.

 

Net debt at the end of FY 2019/20 is expected to be approximately £105m and includes full payment of the annual pension contribution, down from £170.7m at half year 2019/20. This allows the Company to maintain a good level of liquidity headroom under its £275m revolving credit facility, which expires in December 2021.

 

The Group is progressing with its Turnaround Plan announced on 25 February 2020.

 

The Company is monitoring developments related to COVID-19, and actively taking steps to protect its employees in line with guidance from governments. At present, it is too early to quantify the potential impact on FY 2020/21.

Enquiries:

 

De La Rue plc +44 (0)1256 605322/ + 44 (0)7900 165194

Clive Vacher CEO

Rob Harding Interim CFO

Paul Sharma Head of Investor Relations

 

Brunswick Group LLP +44 (0)207 404 5959

Stuart Donnelly/Imran Jina

 

The person responsible for the release of this announcement on behalf of De La Rue is Jane Hyde (General Counsel and Company Secretary).

 

Cautionary note regarding forward-looking statements

 

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "goal", "target", "aim", "may", "will", "would", "could" or "should" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the directors, De La Rue or the Group concerning, amongst other things, the results of operations, profitability, financial condition, liquidity, prospects, growth and strategies of De La Rue and the industry in which it operates.

 

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond De La Rue's ability to control or predict. Forward-looking statements are not guarantees of future performance. The Group's actual results of operations, profitability, financial condition, liquidity, prospects, growth and/or strategy and the development of the industry in which it operates may differ materially from the impression created by the forward-looking statements contained in this announcement. In addition, even if the results of operations, profitability, financial condition, liquidity, prospects, growth and/or strategy of the Group and the development of the industry in which it operates are consistent with the forward-looking statements contained in this announcement, those results or developments may not be indicative of results or developments in subsequent periods.

 

Other than in accordance with its legal or regulatory obligations, De La Rue does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKZGFFVGGGGZM
Date   Source Headline
9th Jul 20201:38 pmRNSHolding(s) in Company
8th Jul 20203:58 pmRNSDirector/PDMR Shareholding
6th Jul 20202:20 pmRNSResults of Capital Raising and General Meeting
3rd Jul 20202:31 pmRNSHolding(s) in Company
2nd Jul 20205:46 pmRNSHolding(s) in Company
1st Jul 202010:46 amRNSBlock listing Interim Review
23rd Jun 202011:48 amRNSHolding(s) in Company
17th Jun 20202:15 pmRNSPublication of Prospectus
17th Jun 20207:01 amRNSProposed Capital Raising
17th Jun 20207:00 amRNS2019/20 FULL YEAR RESULTS AND ANNUAL REPORT 2020
16th Jun 20207:00 amRNSSFO INVESTIGATION CLOSURE
1st Jun 20207:00 amRNSTRADING AND COVID-19 UPDATE
6th May 20207:00 amRNSFULL YEAR ANNOUNCEMENT DATE
27th Apr 20205:57 pmRNSDisclosure of Rights Attached to Equity Shares
1st Apr 202012:28 pmRNSTotal Voting Rights
31st Mar 20207:00 amRNSTrading Update
27th Mar 20209:31 amRNSHolding(s) in Company
24th Mar 202010:35 amRNSHolding(s) in Company
9th Mar 20205:28 pmRNSHolding(s) in Company
5th Mar 20205:44 pmRNSHolding(s) in Company
25th Feb 20205:48 pmRNSHolding(s) in Company
25th Feb 20207:00 amRNSTURNAROUND AND TRADING UPDATE
10th Feb 20202:00 pmRNSCHIEF FINANCIAL OFFICER APPOINTMENT
4th Feb 20206:05 pmRNSDirector Declaration
3rd Feb 20202:38 pmRNSTotal Voting Rights
29th Jan 20203:53 pmRNSHolding(s) in Company
24th Jan 202010:44 amRNSDirectorate Change
7th Jan 20205:13 pmRNSHolding(s) in Company
7th Jan 20205:09 pmRNSDirector/PDMR Shareholding
7th Jan 20205:05 pmRNSDirector/PDMR Shareholding
6th Jan 20204:58 pmRNSHolding(s) in Company
2nd Jan 202010:58 amRNSBlock listing Interim Review
2nd Jan 202010:52 amRNSTotal Voting Rights
19th Dec 20192:58 pmRNSDirector/PDMR Shareholding
16th Dec 201912:46 pmRNSDirector/PDMR Shareholding
4th Dec 20196:19 pmRNSDirector/PDMR Shareholding
3rd Dec 20193:36 pmRNSHolding(s) in Company
2nd Dec 201910:07 amRNSTotal Voting Rights
29th Nov 20192:09 pmRNSDirector/PDMR Shareholding
28th Nov 20194:20 pmRNSDirector/PDMR Shareholding
26th Nov 20196:44 pmRNSDirector/PDMR Shareholding
26th Nov 20197:00 amRNS2019/20 HALF YEAR RESULTS
21st Nov 20193:00 pmRNSAdditional Listing
13th Nov 20193:03 pmRNSHolding(s) in Company
8th Nov 20194:56 pmRNSHolding(s) in Company
31st Oct 20195:05 pmRNSTotal Voting Rights
30th Oct 20197:00 amRNSTrading Update
14th Oct 20193:59 pmRNSCompletion of Sale of ID Business
7th Oct 20195:53 pmRNSHolding(s) in Company
7th Oct 20194:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.